KeraMed Upcoming Conferences & Presentations
Click here to schedule an appointment with KeraMed at ESCRS 2018. The Combined Exhibition of the 36th Congress of the European Society of Cataract and...Read More
Click here to schedule an appointment with KeraMed at AAO 2018 Chicago to Host AAO 2018 Mark Your Calendars! AAO 2018, in conjunction with the...Read More
KeraMed News Room
Clinical Results of the KeraKlear Non-Penetrating Artificial Cornea For Corneal Blindness Yichieh Shiuey, MD and Jose M. Vargas, MD The KeraKlear Artificial Cornea has not...Read More
KeraMed, Inc. is the recipient of the SBA Tibbetts award. The Tibbetts Award honors the SBIR/STTR program participants and supporters that have created a significant...Read More
KeraMed is the recipient of the 2016 Patrick Soon-Shiong Innovation Award presented by the Los Angeles Business Journal. The award ceremony for the 2016 Patrick Soon-Shiong Innovation Awards...Read More
KeraMed is the recipient of the 2016 Patrick Soon-Shiong Innovation Award presented by the Los Angeles Business Journal....Watch Video
In this video Dr. William F. Wiley interviews Dr. Kanellopoulos about the benefits of using the KeraKlear Artificial Cornea. Dr. Kanellopoulos discusses the benefits of...Watch Video
Keraklear Inlay keratoprosthesis in an aniridia keratopathy and glaucoma case. Dr. Kanellopoulos discusses the impantation of the KeraKlear using an intrastromal pocket at 300um using...Watch Video
KeraKlear Artificial Cornea
The KeraKlear is a revolutionary new type of foldable artificial cornea that is designed for synthetic lamellar keratoplasty through small incisions.
The KeraKlear is now available for treatment of all of the most common forms of cornea blindness including: keratoconus, corneal scars, corneal dystrophies, limbal stem cell deficiency, corneal edema and failed corneal transplants.
Can be implanted at depths from 300 microns to 700 microns to replace opacified or edematous corneal tissue.Learn more about the KeraKlear
KeraMed Inc. is an ISO 13485:2003 certified company which specializes in devices for minimally invasive corneal surgery. Each device has been designed to treat corneal conditions using smaller incisions than ever before possible. Smaller incisions can enable faster surgery, faster patient recovery, and maintain the structural strength of the cornea.
The EndoInjector and the KeraKlear Artificial Cornea have received European CE Mark approval.
CAUTION: The EndoInjector and the KeraKlear Artificial Cornea are investigational devices, limited by federal (U.S.) law to investigational use and are not available for sale in the United States.